Steve Kim

Also affiliated with The Barbara Ann Karmanos Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers”.

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0251

N/A

0.533DataRank · unranked

15 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.26.477874

N/A

0DataRank · unranked

1 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.08.481108

N/A

0DataRank · unranked

0 citations

Amro Aboukameel, Yiwei Li, Husain Yar Khan, Rachel Sexton, Sahar F. Bannoura +11 more

Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model

Clinical and Translational Medicine(2023)10.1002/ctm2.1513

N/A

0DataRank · unranked

17 citations

Mohammad Najeeb Al‐Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F. Bannoura +14 more

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.27.534309

N/A

0DataRank · unranked

3 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Data from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers

(2023)10.1158/2767-9764.c.6550541

N/A

0DataRank · unranked

0 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

Cancers(2020)10.3390/cancers12030750

N/A

0DataRank · unranked

38 citations

Gabriel Mpilla, Rachel Sexton, Srikant Viswanadha, Kumar V. Penmetsa, Amro Aboukameel +10 more

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.21.689857

N/A

0DataRank · unranked

0 citations

Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F. Bannoura, Md. Hafiz Uddin, Adeeb A. Aboukameel +27 more